ARAbu Bakarr Rogers

Abu Bakarr Rogers

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Abu Bakarr Rogers has a total of 15 co-authors. Here are the top co-authors by number of shared publications:

  • Aditi Bunker

    Heidelberg Institute of Global Health, Heidelberg University, Heidelberg, Germany

    1 shared publication
  • Andrew Y. Chang

    Center for Innovation in Global Health, Stanford University, Stanford, USA

    1 shared publication
  • Blanca Flores

    Heidelberg University Hospital, Heidelberg, Germany

    1 shared publication
  • George W. Rutherford

    Affiliations Institute for Global Health Sciences, University of California, San Francisco, San Francisco, California, United States of America, Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, California, United States of America

    1 shared publication
  • Grace Wang

    Harvard Medical School, Boston, MA, USA

    1 shared publication
  • J. Daniel Kelly

    Affiliations Institute for Global Health Sciences, University of California, San Francisco, San Francisco, California, United States of America, Partners In Health, Freetown, Sierra Leone, Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, California, United States of America, F.I. Proctor Foundation, University of California, San Francisco, San Francisco, California, United States of America

    1 shared publication

Latest Publications

  • Open Access

    Long-term consequences of food insecurity among Ebola virus disease-affected households after the 2013–2016 epidemic in rural communities of Kono District, Sierra Leone: A qualitative study

    by Manuella L. Djomaleu, Abu B. Rogers, M. Bailor Barrie, George W. Rutherford, Sheri D. Weiser, J. Daniel Kelly

    The 2013–2016 Ebola virus disease (EVD) epidemic caused food insecurity during and immediately following local outbreaks in Sierra Leone, but longer-term effects are less well described, particularly among households with no EVD survivors. We conducted a qualitative sub-study in July 2018 in Kono District, Sierra Leone to understand the impact of food insecurity on EVD-affected households. Using data from a community-based cohort, we compiled a list of all households, within the sampled communities in Kono District, that had at least one EVD case during the epidemic. We used purposive sampling to recruit 30 households, inclusive of 10 households with no EVD survivors, to participate in the study. The research team conducted open-ended, semi-structured interviews with the head of each household. All 30 interviews were transcribed, translated, and analyzed using comparative content analysis consistent with a grounded theory approach. Most household members were facing persistent food insecurity as direct or indirect consequences of the EVD epidemic, regardless of whether they did or did not live with EVD survivors. Three major themes emerged as drivers and/or mitigators of EVD-related food insecurity. Financial instability and physical health complications were drivers of food insecurity in the population, whereas support provided by NGOs or governmental agencies was observed as a mitigator and driver of food insecurity after its removal. Among the EVD-households reporting long-term support through jobs and educational opportunities, there was sustained mitigation of food insecurity. EVD-affected households with and without survivors continue to face food insecurity three years after the EVD epidemic. Provision of support was a mitigator of food insecurity in the short term, but its removal was a driver of food insecurity in the longer term, suggesting the need for longer-term transitional support in affected households.


  • Open Access

    A systematic review of healthcare provider-targeted mobile applications for non-communicable diseases in low- and middle-income countries

    by Pascal Geldsetzer, Sergio Flores, Grace Wang, Blanca Flores, Abu Bakarr Rogers, Aditi Bunker, Andrew Y. Chang, Rebecca Tisdale

    Mobile health (mHealth) interventions hold promise for addressing the epidemic of noncommunicable diseases (NCDs) in low- and middle-income countries (LMICs) by assisting healthcare providers managing these disorders in low-resource settings. We aimed to systematically identify and assess provider-facing mHealth applications used to screen for, diagnose, or monitor NCDs in LMICs. In this systematic review, we searched the indexing databases of PubMed, Web of Science, and Cochrane Central for studies published between January 2007 and October 2019. We included studies of technologies that were: (i) mobile phone- or tablet-based, (ii) able to screen for, diagnose, or monitor an NCD of public health importance in LMICs, and (iii) targeting health professionals as users. We extracted disease type, intervention purpose, target population, study population, sample size, study methodology, technology stage, country of development, operating system, and cost. Our initial search retrieved 13,262 studies, 315 of which met inclusion criteria and were analyzed. Cardiology was the most common clinical domain of the technologies evaluated, with 89 publications. mHealth innovations were predominantly developed using Apple’s iOS operating system. Cost data were provided in only 50 studies, but most technologies for which this information was available cost less than 20 USD. Only 24 innovations targeted the ten NCDs responsible for the greatest number of disability-adjusted life years lost globally. Most publications evaluated products created in high-income countries. Reported mHealth technologies are well-developed, but their implementation in LMICs faces operating system incompatibility and a relative neglect of NCDs causing the greatest disease burden.


  • Open Access

    Equitable and Feasible Distribution of SARS-CoV-2 Vaccines for All in Africa

    by Abu Bakarr Rogers, Mohamed Bailor Barrie, Mosoka P. Fallah, J. Daniel Kelly

    As the fight against the coronavirus disease 2019 (COVID-19) pandemic continues, the necessity for wide-scale, global vaccine rollout to reduce the spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and slow its mutation rate remains unassailable. The COVID-19 Vaccines Global Access (COVAX) initiative’s campaign involves a proportional framework to finance and distribute SARS-CoV-2 vaccines in low- and middle-income countries. However, the COVAX framework has critical limitations, including limited funding and the failure to account for the special epidemic risks and needs of its participating nations, as recommended by the World Health Organization’s Strategic Advisory Group of Experts on Immunization framework. These drawbacks disproportionately impact Africa, where many nations rely on COVAX as their main source of vaccines. The current plan to vaccinate only up to 20% of participating nations’ populations is short-sighted from both epidemiologic and moral perspectives. COVAX must commit to vaccinating all of Africa and its initiative must be modified to account for the health and economic infrastructures in these countries. Lessons learned from successful vaccination campaigns, including the West African Ebola outbreak, have shown that vaccinating all of Africa is possible and feasible, and that infrastructure and human resources can support mass vaccination. To halt this global pandemic, global responsibility must be accepted to finance and equitably distribute SARS-CoV-2 vaccines to African nations. We urge COVAX to act swiftly to prevent Africa from becoming the new face of a persisting pandemic.